| Identification | Back Directory | [Name]
1H-Pyrrole-2-carboxamide, N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[[(1S)-2,2,2-trifluoro-1-methylethyl]amino]sulfonyl]- | [CAS]
1638266-40-6 | [Synonyms]
JNJ6379
JNJ-6379
JNJ 6379
Bersacapavir(JNJ-6379)
Bersacapavir (JNJ-56136379)
Bersacapavir(JNJ 56136379),Bersacapavir(JNJ56136379)
1H-Pyrrole-2-carboxamide, N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[[(1S)-2,2,2-trifluoro-1-methylethyl]amino]sulfonyl]- | [Molecular Formula]
C16H14F4N4O3S | [MOL File]
1638266-40-6.mol | [Molecular Weight]
418.37 |
| Chemical Properties | Back Directory | [density ]
1.47±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (239.02 mM; Need ultrasonic) | [form ]
Solid | [pka]
8.52±0.50(Predicted) | [color ]
Light yellow to khaki |
| Hazard Information | Back Directory | [Uses]
Bersacapavir is a novel Hepatitis B Virus capsid assembly modulator[1]. | [References]
[1] Vandenbossche J, Jessner W, van den Boer M, Biewenga J, Berke JM, Talloen W, De Zwart L, Snoeys J, Yogaratnam J. Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects. Adv Ther. DOI:10.1007/s12325-019-01017-1 |
|
|